• Explore /
  • Poster
  • / Efficacy and safety of HepaSphere drug-eluting bead transarterial chemoembolization combined with hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma.

Efficacy and safety of HepaSphere drug-eluting bead transarterial chemoembolization combined with hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma.

Abstract Poster

Authors

null

Baojiang Liu

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Interventional Therapy, Peking University Cancer Hospital & Institute, Beijing, China, China

Baojiang Liu , Song Gao , Jianhai Guo , Fuxin Kou , Shaoxing Liu , Xin Zhang , Aiwei Feng , Xiaodong Wang , Guang Cao , Hui Chen , Peng Liu , Haifeng Xu , Qinzong Gao , Renjie Yang , Xu Zhu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer - Local-Regional Disease

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 4122)

DOI

10.1200/JCO.2023.41.16_suppl.4122

Abstract #

4122

Poster Bd #

443

Abstract Disclosures

Similar Posters

First Author: Hui Zeng

Poster

2022 ASCO Annual Meeting

Efficacy and safety of low-dose apatinib in advanced hepatocellular carcinoma.

Efficacy and safety of low-dose apatinib in advanced hepatocellular carcinoma.

First Author: Lingbin Meng

First Author: Guoliang Shao

First Author: Xiang Nong